These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 8521383

  • 1. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.
    Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stürzbecher HW, Hoeijmakers JH, Harris CC.
    Cancer Res; 1995 Dec 15; 55(24):6012-6. PubMed ID: 8521383
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
    Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C, Harris CC.
    Oncogene; 2001 Jun 21; 20(28):3620-8. PubMed ID: 11439325
    [Abstract] [Full Text] [Related]

  • 3. Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death.
    Robles AI, Wang XW, Harris CC.
    Oncogene; 1999 Aug 19; 18(33):4681-8. PubMed ID: 10467415
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro.
    Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, Buendia MA.
    Oncogene; 1998 Oct 22; 17(16):2115-23. PubMed ID: 9798683
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC.
    J Gastroenterol Hepatol; 2011 Jan 22; 26 Suppl 1():144-52. PubMed ID: 21199526
    [Abstract] [Full Text] [Related]

  • 7. COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.
    Cheng AS, Yu J, Lai PB, Chan HL, Sung JJ.
    Biochem Biophys Res Commun; 2008 Sep 19; 374(2):175-80. PubMed ID: 18601905
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapeutic drug, adriamycin, restores the function of p53 protein in hepatitis B virus X (HBx) protein-expressing liver cells.
    Yun C, Lee JH, Park H, Jin YM, Park S, Park K, Cho H.
    Oncogene; 2000 Oct 26; 19(45):5163-72. PubMed ID: 11064453
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue.
    Jaitovich-Groisman I, Benlimame N, Slagle BL, Perez MH, Alpert L, Song DJ, Fotouhi-Ardakani N, Galipeau J, Alaoui-Jamali MA.
    J Biol Chem; 2001 Apr 27; 276(17):14124-32. PubMed ID: 11278765
    [Abstract] [Full Text] [Related]

  • 10. Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells.
    Mathonnet G, Lachance S, Alaoui-Jamali M, Drobetsky EA.
    Mutat Res; 2004 Oct 04; 554(1-2):305-18. PubMed ID: 15450428
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression.
    Kim SY, Kim JK, Kim HJ, Ahn JK.
    IUBMB Life; 2005 Sep 04; 57(9):651-8. PubMed ID: 16203685
    [Abstract] [Full Text] [Related]

  • 12. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
    Kwon JA, Rho HM.
    Biol Chem; 2003 Feb 04; 384(2):203-12. PubMed ID: 12675512
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.
    Terradillos O, de La Coste A, Pollicino T, Neuveut C, Sitterlin D, Lecoeur H, Gougeon ML, Kahn A, Buendia MA.
    Oncogene; 2002 Jan 17; 21(3):377-86. PubMed ID: 11821950
    [Abstract] [Full Text] [Related]

  • 15. [Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells].
    Liu XH, Lin J, Cao XZ, Zheng JM, Chen Y, Zhu MH.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 30; 85(12):825-30. PubMed ID: 15949399
    [Abstract] [Full Text] [Related]

  • 16. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
    Lin J, Zhu MH, Qu JH, Li FM, Ni CR.
    Ai Zheng; 2004 Jul 30; 23(7):749-55. PubMed ID: 15248906
    [Abstract] [Full Text] [Related]

  • 17. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D.
    Mol Carcinog; 2009 Jan 30; 48(1):56-65. PubMed ID: 18506760
    [Abstract] [Full Text] [Related]

  • 18. E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter.
    Choi M, Lee H, Rho HM.
    IUBMB Life; 2002 Jun 30; 53(6):309-17. PubMed ID: 12625370
    [Abstract] [Full Text] [Related]

  • 19. Distinctive gene expression profiles associated with Hepatitis B virus x protein.
    Wu CG, Salvay DM, Forgues M, Valerie K, Farnsworth J, Markin RS, Wang XW.
    Oncogene; 2001 Jun 21; 20(28):3674-82. PubMed ID: 11439330
    [Abstract] [Full Text] [Related]

  • 20. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector].
    Joo HY, Han KH, Ryu WS.
    Taehan Kan Hakhoe Chi; 2002 Dec 21; 8(4):371-80. PubMed ID: 12506241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.